title: Calcific uraemic arteriolopathy in a patient with end-stage renal failure and chronic plaque psoriasis: could TNF-α inhibition help ameliorate disease progression?
authors: Departments of Dermatology and Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
authors: Aaron James
authors: AJ
authors: Robinson
authors: Jenny
authors: J
authors: Nicolopoulos
authors: Eugenie
authors: E
authors: Pedagogos
authors: Barbara
authors: B
authors: Radulski
authors: George A
authors: GA
authors: Varigos
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002115:Calciphylaxis / Q000150:complications* / Q000188:drug therapy; D018450:Disease Progression; D004697:Endocarditis, Bacterial / Q000150:complications; D000068800:Etanercept / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept